Notch is a transmembrane receptor functioning in the determination of cell fate. Abnormal Notch signaling promotes tumor development, showing either oncogenic or tumor suppressive activity. The uncertainty about the exact role of Notch signaling, partially, stems from inconsistencies in descriptions of Notch expression in human cancers. Here, we clarified basal-cell dominant expression of NOTCH1 in squamous epithelium. NOTCH1 was downregulated in squamous neoplasms of oral mucosa, esophagus and uterine cervix, compared with the normal basal cells, although the expression tended to be retained in cervical lesions. NOTCH1 downregulation was observed even in precancers, and there was little difference between cancers and high-grade precancerous lesions, suggesting its minor contribution to cancer-specific events such as invasion. In culture experiments, reduction of NOTCH1 expression resulted in downregulation of keratin 13 and keratin 15, and upregulation of keratin 17, and NOTCH1 knockdown cells formed a dysplastic stratified epithelium mimicking a precancerous lesion. The NOTCH1 downregulation and the concomitant alterations of those keratin expressions were confirmed in the squamous neoplasms both by immunohistochemical and cDNA microarray analyses. Our data indicate that reduction of NOTCH1 expression directs the basal cells to cease terminal differentiation and to form an immature epithelium, thereby playing a major role in the histopathogenesis of epithelial dysplasia. Furthermore, downregulation of NOTCH1 expression seems to be an inherent mechanism for switching the epithelium from a normal and mature state to an activated and immature state, suggesting its essential role in maintaining the epithelial integrity.
Notch is a transmembrane receptor that regulates cell proliferation and differentiation in various tissues. Notch is constitutively processed and is tethered on the plasma membrane as a heterodimeric protein, and the signal is transduced by the Notch intracellular domain (NICD) produced by ligand-induced cleavage, 1,2 which translocates to the nucleus and directly induces the transcription of downstream targets by forming a transactivation complex with several cofactors. 3 In humans, there are four Notch homologs (NOTCH1, 2, 3, 4) and they exhibit diverse patterns of expression, suggesting different contributions in each tissue.
The expression of Notch1, Notch2 and Notch3 in mouse skin and hair follicles has been documented, [4] [5] [6] [7] and Notch signaling seems to have important roles in the regulation of epidermal differentiation. Conditional knockout of Notch1 in skin results in epidermal and corneal hyperplasia. 8 Overexpression of constitutively active Notch1 in basal cells leads to hyperplastic epidermis and abnormal hair development. 4, 9 In contrast, deletion of Notch2, Notch3 and Notch4 does not cause significant changes in the epidermis. 6, 10, 11 These results indicate the significance of Notch1 in epidermal differentiation.
Abnormal Notch signaling can promote tumor development. The first indication that Notch has a role in carcinogenesis was obtained from a mouse mammary tumor virus integration assay in which four genes were identified as candidates that associate with tumor progression, the third of which (int-3) turned out to be a truncated form of Notch4.
Gain of function mutation of NOTCH1 was detected in many cases of T-cell acute lymphoblastic leukemia, 13 and this finding gave rise to the concept of treatment by inhibiting the formation of Notch transactivation complex. 14 In cervical cancer, the upregulation of NOTCH1 15, 16 and NOTCH2, 16 and an increase in nuclear localization of NICD 17 were documented. On the basis of these observations, activation of Notch signaling is thought to be associated with the development of cervical cancer. 18 However, promotion of carcinogenesis by Notch signal activation seems contradictory to the phenotypes observed in the Notch1 knockout mouse, which exhibits an increase in the incidence of papilloma and chemical-induced skin cancer, 8 and the transgenic mouse of the pan-Notch inhibitor, dominant-negative Mastermind-like 1, which shows dysplasia and SCC of skin. 19 In fact, expression of NOTCH1 is decreased in skin cancer, 20, 21 suggesting that NOTCH1 acts as a tumor suppressor. To solve the discrepancy of the proposed role of Notch, accurate knowledge of its expression is crucial. To assess its contribution in cancer, the Notch expression should be evaluated in comparison with the normal cells from which the cancer cells originated. However, it appears that the expression of Notch in human cancers has not been properly evaluated along this line. Even the localization of Notch proteins in normal adult tissue is unclear, partially, because of the difficulty of detection.
To address this issue, we have engaged in an examination of Notch expression in adult human tissues. In this study, we first demonstrate that NOTCH1 is predominantly expressed in the basal cells of normal squamous epithelium. Then we expand the examination to neoplasms that have originated from squamous epithelium and show that Notch1 expression is downregulated in these lesions. Cell culture experiments indicate that reduction of NOTCH1 expression associates with abnormal differentiation represented by alteration of keratin subtype expression. Our data suggest that aberrant epithelial differentiation in squamous neoplasms is caused by the reduction of NOTCH1 expression, which in turn unveils its essential function in the maintenance of normal epithelial integrity.
MATERIALS AND METHODS Clinical Specimens
A total of 56 specimens of oral lesions (epithelial dysplasia and squamous cell carcinoma) were collected at the Dental Hospital of Tokyo Medical and Dental University. Pharyngeal cancers were excluded; the case summaries are shown in Supplementary Material 1. A total of 20 specimens of esophageal lesions (squamous cell carcinoma) and normal tissues were collected at Medical Hospital of Tokyo Medical and Dental University; the case summaries are shown in Supplementary Material 2. A total of 57 specimens of uterine cervical lesions (intraepithelial neoplasm and squamous cell carcinoma) were collected at Keio University Hospital; the case summaries are shown in Supplementary Material 3. The tissues were fixed in formalin and embedded in paraffin according to the routine laboratory protocol. HPV genotyping was performed as previously described 22 from the conventional cytology specimens. All experiments were approved by the ethics committees of both universities.
cDNA Microarray Analysis Oral squamous cell carcinoma (OSCC) cells were taken from surgically excised specimens by laser capture microdissection and were subjected to cDNA microarray analysis, as previously described. 23 Immunostaining and In Situ Hybridization Immunohistochemical staining was performed using the Sequenza (Thermo Fisher Scientific, MA, USA). For antigen retrieval, the sections were autoclaved in alkaline buffer (10 mM Tris (pH ¼ 9.0) and 1 mM EDTA) at 120 1C for 20 min. The primary antibodies used in this study were antiNotch1 (EP1238Y, Epitomics, CA, USA); cleaved Notch1 (Val1744; D3B8, Cell Signaling, MA, USA) Notch2 (D67C8, Cell Signaling); Notch3 (D11B8, Cell Signaling); Hes1 (EPR4226, Epitomics); Hey1 (polyclonal, Millipore, MA, USA); keratin 5 (K5; EPR1600Y, Epitomics); K13 (EPR3671, Epitomics); K13 (alternative antibody, KS-1A3, Leica Microsystems, Wetzlar, Germany); K15 (EPR1614Y, Epitomics); K17 (D73C7, Cell Signaling); K17 (alternative antibody, E3, Dako, Glostrup, Denmark); K18 (DC10, Dako); pan-Keratin (AE1/AE3, Dako); Vimentin (SP20, Epitomics); E-cadherin (36/E-Cadherin, BD transduction laboratories, CA, USA); Desmoglein3 (3G133, Santa Cruz, CA, USA); p63 (4A4, Dako); b-tubulin (9F3, Cell Signaling) and b-actin (C-2, Santa Cruz). EnVision Dual Link (Dako) was used as the secondary antibody. Coloration was done in DAB substrate. For immunofluorostaining, Alexa Fluor 488 anti-rabbit IgG (Invitrogen, CA, USA) and DAPI were used. In situ hybridization to mouse E18.5 embryos was conducted as previously described. 24 Antibody adsorption test was performed as follows. HEK293 cells were transfected with Notch1 or NOTCH3 and were fixed 48 h after transfection. The anti-NOTCH1 or anti-NOTCH3 antibody (diluted 1/500) was applied to the fixed cells, respectively, and incubated for 1 h. The adsorbed supernatants were collected and used for immunohistochemical staining. The immunostaining results were compared with that using the antibody adsorbed to mock-transfected cells.
Protein Extraction from Formalin-Fixed ParaffinEmbedded Specimens
Formalin-fixed paraffin-embedded specimens were sectioned at 10 mm thick and deparaffinized. Tissues were manually dissected under a microscope. The collected tissues were heated at 95 1C for 1 h and then at 60 1C for 4 h in the protein extraction buffer (50 mM Tris (pH ¼ 8.0), 5 mM EDTA, 2% SDS).
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Genes
Mouse Notch1 was provided by Dr J. Nye and constitutive active Notch1 were previously described. 25 Notch extracellular domain (NECD) was created by ligating the PCR amplified Notch1 extracellular and transmembrane regions (1 M to 1755G) into pAcGFP1-C2 (Clontech). Human Notch3 was provided by Dr A. Joutel. Rbpj cDNA was provided by the RIKEN BioResource Center (Ibaraki, Japan) courtesy of Dr T. Honjo and cloned into pCMV-Tag4 (Stratagene, CA, USA), and dominant-negative Rbpj (R218H) was created by PCR mutagenesis. Dominant-negative Dll1 (chick) was previously described. 26 Human TP63a(TA) was purchased from Invitrogen. TP63a(DN) was created as follows. A plasmid (pBK-CMV-dN) was made, which contained the sequence corresponding to the TP63a(DN)-specific N-terminal region by ligating annealed oligoniculeotides into pBK-CMV (Stratagene). As the N-terminal TP63a(TA)-specific region incidentally coincides to 5 0 of MSC1 site, the N-terminal region was deleted from TP63a(TA) by MSC1 digestion, and the fragment was ligated into pBK-CMV-dN. The resulting plasmid was confirmed by DNA sequencing to carry TP63a(DN) identical to the wild type. Human KRT13 and KRT15 promoters were cloned by PCR from the BAC clone RP11-156A24, and human KRT17 promoter was cloned from the BAC clone RP13-415G19, both of which were provided by the BACPAC Resources Center (CA, USA). The sequences of the PCR primers used in the cloning procedures will be provided on request. Stealth RNAs for human NOTCH1 were purchased from Invitrogen. The sequence of the plus strand of the dsRNA is 5 0 -UCGCAUUGACCAUU-CAAACUGGUGG-3 0 .
Cell Culture Experiments GE-1, Ca9-22, HeLa and CaSki cells were provided by the RIKEN BioResource Center. HSC-3 and 293 cells were provided by the Japanese Collection of Research Bioresources (Osaka, Japan). Human foreskin (HFS) cells were purchased from Kurabo (Osaka, Japan). Transfections were performed using Lipofectamine 2000 (Invitrogen) or by calcium phosphate method. Cell proliferation was evaluated using a Cell Counting Kit (Dojindo, Kumamoto, Japan). Cells were lysed in RIPA buffer and the concentration of the protein was measured using a BCA Protein Assay Kit (Thermo Fisher Scientific, MA, USA). Western blot analysis and RT-PCR were performed according to standard protocols. 27 Threedimensional culture was conducted using Millicell Culture Inserts (Millipore). Real-time RT-PCR was performed using a Lightcycler (Roche, Basel, Switzerland). The PCR primer sequences are as follows: hN1-5865F, 5
Luciferase Activity Assay KRT13, KRT15 and KRT17 promoter fragments were cloned as described in the Genes section, and ligated into pGL4.10.
(Promega, WI, USA). The promoter construct of 0.1 mg, 0.1 mg of the Notch1 construct and 0.01 mg of the Renilla luciferase standardization plasmid were transfected into GE-1 cells on 48-well plates and the luciferase activity was measured 48 h after transfection using a Dual-Luciferase Reporter Assay System (Promega). All transfections were done in triplicate and the experiments were repeated at least twice.
RESULTS

Expression of NOTCH1 in Basal Cells of Squamous Epithelium
In the pilot study, we screened for optimal antibodies that clearly detect an endogenous level of Notch in western blot analysis. The selected antibodies revealed that NOTCH1, NOTCH2 and NOTCH3 were expressed in primary HFS cells and HEK293 cells, whereas NOTCH4 was not detected (data not shown). This result was confirmed by RT-PCR analysis, which revealed expression of NOTCH1, NOTCH2 and NOTCH3 but not NOTCH4 (data not shown). These (anti-NOTCH1 and anti-NOTCH3) antibodies reacted with recombinant Notch1 (mouse) and NOTCH3 (human), respectively, which were overexpressed in HEK293 cells as well as with the endogenous proteins, as revealed both by western blot analysis and immunofluorescent staining, validating their specific reactions (Supplementary Material 4A, B). We then examined their immunohistochemical expression in various human adult tissues. Distinct expression of NOTCH1 was observed in the basal cells of squamous epithelium ( Figure 1a ). This was consistent with the result of in situ hybridization, which exhibited basal-cell expression of Notch1 in an embryonic mouse skin ( Figure 1b ). The NOTCH1 protein was detected mainly on the plasma membrane, which is consistent with its function as a transmembrane receptor ( Figure 1a ). Nuclear staining was rarely observed. Antibody adsorption test showed significantly reduced staining when the antibody was absorbed to Notch1-transfected cells, validating the usability in immunohistochemical detection (Supplementary Material 4C). Both cornifiedand non-cornified squamous epithelia expressed NOTCH1. The expression in the esophagus and vagina appeared weaker than that in the skin and oral mucosa (Figure 1c) , suggesting that the epithelium of ectodermal origin (skin, oral mucosa) expresses NOTCH1 more than that of endodermal origin (esophagus, vagina). Basal (myoepithelial) cells in the secretory glands were weakly Notch1 in squamous neoplasms K Sakamoto et al positive for NOTCH1 (data not shown). In the uterus, the columnar epithelium, including subcolumnar reserve cells, was almost negative for NOTCH1. In the digestive tract, NOTCH1 was detected faintly only in the basal crypts (data not shown). In the subepithelial tissue, NOTCH1 was detected weakly in the vascular endothelial cells (data not shown). NOTCH3 was also expressed in the basal cells of squamous epithelium, showing membranous localization ( Figure 1a ). The staining pattern of NOTCH3 was a little different from that of NOTCH1, showing weak ubiquitous cytoplasmic staining also in glandular cells (data not shown). This staining in glandular cells seemed nonspecific because it did not decrease when the adsorbed antibody was used, whereas the staining in the basal cells weakened (data not shown). The NOTCH2 antibody was not applicable to immunohistochemical detection, showing no staining in any tissues (data not shown). In summary, NOTCH1 and NOTCH3 were expressed mainly in the basal cells of squamous epithelium.
NOTCH1 Expression Is Downregulated in Squamous Neoplasms
As the anti-NOTCH3 antibody yielded some nonspecific staining that would hamper correct evaluation, we determined to focus on NOTCH1 in this study and expanded our investigations to neoplasms. Because the squamous epithelia were dominant sites of NOTCH1 expression, we chose squamous neoplasms that develop at these sites and investigated whether the expression is upregulated, downregulated or unchanged. For this purpose, we collected surgical specimens of squamous cell carcinoma (cancer). To assess the contribution of NOTCH1 in cancer progression, surgical specimens of intraepithelial neoplasm (precancer) were also collected. To compensate for the organ-specific differences, specimens were collected from three different tissue sources-oral mucosa, esophagus and uterine cervix.
First we examined the NOTCH1 expression in 56 cases of oral epithelial neoplasm, including OSCC and oral intraepithelial neoplasm (OIN). We randomly collected specimens that contained normal epithelium, and the expression was evaluated by the staining intensity in individual tumor cells in comparison with that in normal basal cells within the same specimen. The distinct staining pattern with abrupt changes at the interface between normal epithelium and neoplasm enabled us to adopt this methodology. The expression was scored as being at one of five levels: level 4, upregulated expression compared with the normal basal cells; level 3, expression level similar to the normal basal cells (equivalent to ' þ þ ' in Figure 1c ); level 2, expression level less than the normal basal cells; level 1, stained only faintly . The downregulation was observed even in the precancerous lesions with minimum histopathological changes (OIN1) and was apparent in most of the precancerous lesions with moderate histological alterations (OIN2), the lesions with prominent histological alterations (OIN3), and OSCC (Figure 2d ). There were no cases showing an increase of NOTCH1 expression. No significant correlation was observed between the level of NOTCH1 expression and the histological variations of OIN or the histological differentiation grade of OSCC. To confirm the immunohistochemical evaluation, we dissected normal tissues and cancers separately from the sections, extracted proteins and conducted western blot analysis. In all, 4 out of 10 cases were informative, all of which showed reduced NOTCH1 expression in cancer, normalized to keratin 5 ( Figure 2e ). This result is consistent with the immunohistochemical observations. Proteins of sufficient amount and quality were not obtained from the other six specimens, probably due to the fixation period. The downregulation of NOTCH1 in OSCC was also confirmed by cDNA microarray analysis of 41 OSCC vs 7 normal oral epithelia (Po0.001), with the average expression in OSCC reduced to 0.43-fold compared with the normal control ( Figure 2f ). The cDNA microarray showed that NOTCH2 and NOTCH3 were also downregulated in OSCC to 0.78-fold and 0.83-fold, respectively (data not shown). Next, we examined the immunohistochemical expression of NOTCH1 in squamous cell carcinoma of esophagus (ESCC; Supplementary Material 2 and 5). Downregulation was evident in 17 out of 20 cases while weak expression remained. The remaining three cases retained a considerable expression, but there were no cases with NOTCH1 upregulation.
Next, we examined the immunohistochemical expression of NOTCH1 in uterine cervical lesions (Supplementary Material 3, 6). NOTCH1 expression tended to be downregulated in cervical intraepithelial neoplasm (CIN) and cervical squamous cell carcinoma (CSCC). However, more than 50% of the cases retained considerable expression (Supplementary Material 6). More cases showed NOTCH1 downregulation in precancerous lesions with little tendency of differentiation (CIN3 and CSCC), compared with precancerous lesions with some tendency of differentiation (CIN1 or CIN2). No significant difference was observed between CIN3 and CSCC (Supplementary Material 6). There was not a single case showing apparent NOTCH1 upregulation in the individual cancer cells. Indistinct nuclear staining was occasionally observed, but most of the neoplastic cells exhibited a membranous or cytoplasmic staining. No significant correlation was observed between the level of NOTCH1 expression and the type of HPV detected in the lesion (Supplementary Material 3) .
In summary, the NOTCH1 expression was downregulated both in precancer and cancer of non-cornified squamous epithelium.
NOTCH1 Regulates the Differentiation of Squamous Epithelium
The fact that NOTCH1 was downregulated not only in cancer but also in precancer suggests that aberrant NOTCH1 expression associates with changes of epithelial properties observed both in precancers and cancers. The essential properties that discriminate cancer from precancer are invasion and resultant metastasis, and our data suggest that the downregulation of NOTCH1 may not contribute to these cancer-specific events. In contrast, dysregulation of differentiation is a common feature observed both in cancer and precancer, appearing as abnormality of cell alignment, stratification and keratinization. Considering that Notch governs cell-to-cell signaling, we hypothesized that reduction of Notch signaling might affect the cell-to-cell-based regulation of epithelial differentiation. To test this hypothesis, we conducted cell culture experiments. First, we examined Notch expression in cell lines derived from cervical cancers (HeLa, CaSki), oral cancers (BHY, Ca9-22, HSC-3) and primary HFS cells. Western blot analysis revealed that both NOTCH1 and NOTCH3 were expressed most abundantly in the normal cells, and variably, but at much lower levels, in the cancer cell lines (Figure 3a) , which is a finding consistent with the observation that NOTCH1 expression was downregulated in squamous neoplasms. NOTCH2 was considerably expressed (Figure 3a) . To assess the possible correlation between NOTCH1 and differentiation, we examined the expression of epithelial markers in these cells (Figure 3b) . In normal noncornified squamous epithelium, the basal cells express NOTCH1, K15, K19, CDH1, DSG3 and TP63, whereas K16 and K17 expression is weak, and K18 and vimentin are not expressed (data not shown). HFS cells mimicked this expression pattern. The cancer cell lines showed various expression patterns, reflecting the diversities in differentiation states of each cell line (Figure 3b ). When we compared the two cervical cancer cell lines, CaSki expressed more NOTCH1 and exhibited a phenotype more similar to normal epithelium than to HeLa. When we compared the three oral cancer cell lines, Ca9-22 that expressed a significantly higher level of NOTCH1 than BHY and HSC-3 exhibited the phenotype very similar to normal epithelium. When the cells were cultured at a high density, HFS and Ca9-22 cells spontaneously differentiated, showing scattered cells positive for K13, a keratin in terminally differentiated keratinocytes (Figure 3c ). The other cancer cells showed little potential to express K13. These results suggest that NOTCH1 expression may associate with differentiation of non-cornified epithelium. Cervical cancer cells, which do not fit into this hypothesis, will be discussed in the Discussion section.
As Ca9-22 mimicked well the phenotype of normal epithelium, and Ca9-22 cells were easily transfected, we thought that they served as a good cell model for assessing differentiation. Accordingly, we examined the effects of Notch signaling in Ca9-22 cells. We treated Ca9-22 cells with gamma-secretase inhibitor (DAPT), which blocks the Notch signaling, and examined K13, K15 and K17 expression after 72 h. These keratins are expressed variably in physiological and pathological conditions, and represent distinct cellular states; K13 represents keratinocytes under terminal differentiation, K15 represents basal cells and K17 represents activated keratinocytes such as those appearing in regenerative epithelium and cancer. DAPT treatment led to reduced expression of a putative downstream target of Notch signaling, HES1, and K13 expression, whereas K15 and K17 levels were largely unchanged (Figure 3d ), suggesting that Notch signaling is necessary for terminal differentiation. Next the cells were transfected with various constructs (Figure 3e) . Constitutively, active Notch1 (NICD) upregulated HES1 and suppressed K13, suggesting that sustained, high-level Notch signaling inhibits terminal differentiation. Knockdown of NOTCH1 by siRNA led to a decrease of HEY1, another putative target of Notch signaling, K13 and K15, and an increase of K17. Rbpjm, which is a mutant Rbpj with a single aminoacid replacement (R218H), and dnDl, which is a deletion mutant of Dll1, are both known to pose a dominant-negative effect on Notch signaling. Both constructs led to a decrease of HEY1 and an increase of K13. These results indicate that proper expression of NOTCH1 and its signaling are necessary for terminal differentiation, and either the absence of its signaling or its untimely activation results in abnormal differentiation. It should be noted that the phenotype observed in NOTCH1 knockdown differed from that in the autonomous inhibition of Notch signaling.
We examined the correlation of TP63, a transcription factor that regulates keratinocyte differentiation, with NOTCH1. Among different isoforms, the most abundant TAand DN-isoforms were examined. In uterine cervical cells, TP63(DN) acts as a transcriptional repressor of NOTCH1, which results in maintenance of self-renewing capacity. 28 In Ca9-22 cells, transfection of TP63(DN) only slightly decreased NOTCH1 expression and TP63(TA) did not have a significant effect on NOTCH1. Both TP63(TA) and TP63(DN) decreased K13 expression (Figure 3f) . NICD overexpression and NOTCH1 knockdown both led to downregulation of TP63(DN) and K13 (Figure 3g ). These results indicate that TP63(DN) inhibits differentiation partially by repressing NOTCH1 expression, whereas Notch signaling also mediates TP63(DN) expression.
To further investigate the contribution of Notch signaling in regulation of keratin subtype expression, we conducted A small amount of full-length protein was also detected. Gamma-secretase-cleaved C-terminal fragment (NICD) was not observed in NOTCH1 and NOTCH3 blots. (b) Expression of various keratins (K), vimentin (Vim), E-cadherin (Cdh1), desmoglein 3 (Dsg3) and TP63 in various cells, as revealed by western blot. As the full-length NOTCH1 was observed at a much weaker intensity and in proportion to the intensity of the 120 kDa protein, only the 120 kDa protein of NOTCH1 is shown. (c) K13 expression in Ca9-22 and HFS cells cultured at a high density. Immunofluorostaining was conducted using the secondary antibody labeled by Alexafluor 488. The nuclei were counterstained by DAPI. K13-expressing cells appear in a scattered manner. HeLa, CaSki, BHY and HSC-3 showed no K13 expression. (d) Ca9-22 cells were treated with only DMSO or 2.5 mM DAPT at 80% confluency and were cultured for 72 h. An equal amount of protein was subjected to western blot analysis for keratins (K), HES1, HEY1 and b-tublin (bTub). (e) Ca9-22 cells were transfected at 30% confluency with an empty plasmid (Ctrl), NICD, dominant-negative RBPJ (R218H, RBPJm), dominant-negative Dll1 (dnDl) or siRNA for NOTCH1 (siN1) and were cultured for 72 h. (f) Ca9-22 cells were transfected with TP63(TA) or TP63(DN) and were incubated for 72 h. Western blot analysis revealed the endogenous expression of TP63 (DN), but not TP63 (TA). NOTCH1 was only slightly downregulated by TP63 (DN). K13 was downregulated both by TP63 (TA) and TP63 (DN). (g) Ca9-22 cells were transfected with NICD or siRNA for NOTCH1 and were incubated for 72 h. Both NICD and siN1 downregulated TP63 and K13. (h) Luciferase reporter assay for human KRT13, KRT15 and KRT17 promoters. The promoter construct plus of 0.1 mg and 0.1 mg of the Notch1 construct and 0.01 mg of the Renilla luciferase standardization plasmid (pEF-RL). Transfections were done into GE-1 cells on 48-well plates and the luciferase activity was measured 48 h after transfection using Dual-Luciferase Reporter Assay System (Promega). The error bars denote standard errors. rlu; relative luciferase unit.
Notch1 in squamous neoplasms K Sakamoto et al promoter analysis of the keratin genes using GE-1 cells that were established from normal mouse gingival epithelium. We co-transfected the cells with Notch1, NICD or NECD, and the luciferase reporter constructs for KRT13, KRT15 or KRT17 promoters. NECD is a membrane-tethered Notch1 extracellular domain whose intracellular domain was replaced by AcGFP. Notch1 increased the KRT13 promoter activity while NICD decreased it. NECD decreased the KRT15 promoter activity and slightly increased the KRT17 promoter activity (Figure 3h ). These results suggest that NOTCH1-expressing cells have more potential to differentiate, but Notch signaling itself autonomously inhibits differentiation and directs the cell to maintain basal-cell phenotype.
Next we examined the effect of NOTCH1 knockdown in normal epithelial cells using the primary HFS cells. The knockdown efficiency was more than 90% as revealed by Notch1 in squamous neoplasms K Sakamoto et al western blot analysis (Figure 4a ). NOTCH1 knockdown significantly suppressed the expression of HEY1, whereas HES1 showed only slight (20%) reduction, as revealed by real-time PCR (Figure 4b , real-time PCR data are not shown). Cell proliferation was not altered by NOTCH1 knockdown (data not shown). The total amount of keratin protein was unchanged, and vimentin was not induced by NOTCH1 knockdown (Figure 4c ). NOTCH1 knockdown led to downregulation of K13 and K15, and upregulation of K17. Immunocytostaining using the anti-K13 antibody revealed that NOTCH1 knockdown resulted in a decrease both of the staining intensity in individual cells and of the number of stained cells (Figure 4d ). The expression of CDH1 (E-cadherin), DSG3 (desmoglein 3) and TP63 was not significantly (Figure 4c) . In a three-dimensional culture, the NOTCH1-knockdown cells formed a stratified epithelium that exhibited a thickened cell layer and a disarray of stratification (Figure 4e ), which are reminiscent of the histological features of precancer. These results suggest that reduced NOTCH1 expression results in conversion from a differentiated epithelium to an immature or hyperplastic epithelium represented by K17 expression.
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Correlation Between NOTCH1 and Keratin Subtype Expression in Tissue
To validate the results obtained by cell culture experiments, we immunohistochemically examined the keratin expression in cancer and precancer of oral mucosa, esophagus and uterine cervix. NOTCH1 and K13 were concomitantly downregulated along with downregulation of K15 and upregulation of K17 in most oral and esophageal lesions ( Figure  5a ). In cervical lesions, a similar tendency was observed. However, there were also cases with considerably retained NOTCH1 expression, and NOTCH1-retained lesions showed a different keratin pattern, namely, K15-positive basaloid cell expansion with minimum induction of K17 (Figure 5b) . We scored the K13 expression either as being at level 2 (unaffected, almost uniform expression), level 1 (apparent downregulation but patchy expression remaining) or level 0 (almost complete loss of expression), and analyzed the correlation of these three expression levels with the NOTCH1 scores. Loss of K13 expression was observed in accordance with NOTCH1 downregulation (Figure 5c ). The average scores of K13 and NOTCH1 decreased in accordance with the grades of OIN and CIN, although the high-grade lesions (OIN2, OIN3, CIN3) showed scores similar to those of OSCC or CSCC (Figure 5c ), indicating that these precancers and cancers in each site are essentially the same lesions in the context of NOTCH1 and K13 expression. The cervical lesions, especially low-grade CIN, tended to show more NOTCH1 and K13 expression. Correlation between NOTCH1 expression and keratin expression was further assessed in oral cancers using microarray data. Scatter plots revealed that the downregulation of NOTCH1 in cancer correlated with downregulation of K13 and K15, and upregulation of K17 ( Figure 6 ).
Asymmetric Activation of NOTCH1
In tissue, NOTCH1 was dominantly observed on the cell membrane, and nuclear staining was rarely seen. To gain an insight into when and how NOTCH1 is activated, its cellular localization was further investigated in HFS cells. NOTCH1 was detected on the cell membrane of culture cells, showing accumulation at the cell-cell interface (Figure 7a) . No NOTCH1 accumulation was observed on the free surfaces. Western blot analysis, using cleaved NOTCH1-specific antibody, failed to detect activated NOTCH1 (data not shown), probably due to low expression. Still, immunostaining showed distinct nuclear expression of activated NOTCH1, but only in a very few (o1%) cells (Figure 7b ). This suggests that NOTCH1 protein is tethered to the cell membrane and is dormant in most cells, and that it is activated only in a limited population or on infrequent occasions. We further assessed nuclear translocation of NOTCH1. As the endogenous level of NOTCH1 expression was not sufficient for clear visualization, we overexpressed Notch1 by transfection and examined cellular localization of the protein. Again, cells whose nuclei were positive for Notch1 were rare but were definitely observed. Interestingly, nuclear localization of Notch1 was occasionally observed in one of two neighboring cells, which appeared as postmitotic daughter cells (Figure 7c ).
DISCUSSION
We demonstrated that NOTCH1 is expressed predominantly in the basal cells of normal squamous epithelium. Contrary to our findings, previous reports had documented the expression in both basal and suprabasal layers of the skin 4, 21 and in the uterine cervix, 15, 16 as well as in the suprabasal layer of the cornea, 29 but we believe the present study correctly demonstrates the basal-cell dominant NOTCH1 expression in human squamous epithelium and its neoplasms. The most prominent feature that supports the validity of our immunohistochemical examination is the sharp demarcation of NOTCH1 expression that matched to the border between Notch1 in squamous neoplasms K Sakamoto et al normal and neoplastic epithelia, which would never be observed in nonspecific staining.
Although elevated Notch signaling has been suggested in tumor development, 13, [30] [31] [32] neither an increase of NOTCH1 expression nor its nuclear translocation was observed in the cases we examined. The cDNA microarray of OSCC showed that neither NOTCH2 nor NOTCH3 was upregulated in OSCC, suggesting that quantitative compensation is unlikely. These results indicate that upregulation of Notch-dependent signaling may not make a major contribution to the development and progression of squamous cell carcinoma. Conversely, consistent reduction of NOTCH1 expression in squamous neoplasms was evident. Also, NOTCH1 has recently been shown to be mutated in 11-15% of head and neck cancer, and about 40% of the mutations were predicted to generate truncated NOTCH1 proteins, whereas no apparent activating mutation was found. 33, 34 These results suggest that NOTCH1 may function as a tumor suppressor gene rather than as an oncogene in squamous neoplasms.
We demonstrated that impaired Notch1 signaling led to abnormal differentiation represented by alterations of keratin subtype expression, which was commonly observed not only in cancers but also in precancers. The role of Notch in regulation of squamous epithelium differentiation has also been suggested by studies using cultured cervical 28 and esophageal keratinocytes. 35 Collectively, these results indicate that Notch1 in squamous neoplasms K Sakamoto et al reduced NOTCH1 expression affects the terminal differentiation, thus highlighting the essential role of NOTCH1 in maintaining normal epithelial integrity. In addition, we examined five cases of traumatic ulcer and found that NOTCH1 was downregulated in the regenerative epithelium, accompanied with loss of K13 expression and robust induction of K17 (K.S., unpublished observations). This suggests that the downregulation of NOTCH1 expression level is an inherent mechanism for switching the epithelium from a normal and mature state to an activated and immature state. Cervical cancers tended to retain NOTCH1 expression compared with oral and esophageal cancers. We evaluated the expression in the cervical cancer cells in comparison with the neighboring vaginal squamous epithelium. However, this evaluation method might be misleading because cervical cancers arise from the reserve cells beneath the columnar epithelium of endocervix, 36 and the vaginal epithelium is not the origin of cervical cancers. As the reserve cells are almost negative for NOTCH1, it can also be said that NOTCH1 expression is increased in cervical cancer compared with its original cell type.
We hypothesized that strong NOTCH1 expression may correlate with a tendency for differentiation toward squamous epithelium. To check this hypothesis, we additionally examined five specimens of squamous metaplasia caused by obstruction of the minor salivary gland duct. As expected, NOTCH1 was significantly induced in ducts, which show ectopic K13 induction and squamous metaplasia (Supplementary Material 7) . HPV infection to metaplastic epithelium in the transformation zone initiates progression to CIN or CSCC, 37 and NOTCH1 is upregulated by HPV E6 and E7 oncoproteins, which are almost uniformly expressed in cervical cancer. 38 Virally induced NOTCH1 expression would tend to be maintained in CIN and CSCC, but would be no more upregulated. In this context, upregulation of NOTCH1 may have an essential role only in generation of metaplastic epithelium.
HPV has been detected only in a minority of OSCC cases, excluding pharyngeal cancer 39 and ESCC. 40 This is probably attributable to the difference in the NOTCH1 expression pattern between oro-esophageal and cervical cancers. The NOTCH1 expression patterns seem to underlie their histopathological differences. Expansion of a basaloid cell population is usually observed in CIN, whereas this finding is exceptional in OIN, whose basaloid cells are usually limited to the lower part of the epithelium. Remaining NOTCH1 Notch1 in squamous neoplasms K Sakamoto et al expression appears to autonomously direct the cell to maintain the basaloid phenotype.
In our series of cell culture experiments, Notch signaling exhibited seemingly diverse effects. For example, both activation of Notch signaling and downregulation of NOTCH1 expression inhibited differentiation. To better understand such diverse effects, we have developed the following model, which is consistent with the experimental and histopathological findings, and also with the self-organizing nature of stratified epithelium. NOTCH1 is selectively activated in the basal cell when the sister cell divides basoapically, and acts to direct the basal cell to remain as a basal cell, whereas the apical daughter cell without Notch signal input is directed to differentiate (Figure 8a) . When the sister cell divides laterally, Notch is activated in both cells, which directs them both to be basal cells (Figure 8b ). If asymmetric Notch signaling is impaired, and both basal and apical daughter cells undergo Notch activation, both would remain as basaloid cells (Figure  8c ), causing expansion of the basal-cell layer. Cells with reduced NOTCH1 expression convert to activated cells that lead to a hyperplastic phenotype (Figure 8d ). In either case, impaired Notch signaling causes an immature epithelium. Although future research is required to confirm this model, it is consistent with the results of genetically engineered mouse experiments. 8, 35 Besides its role as a receptor, Notch is considered to have a function as a modulator of cell adhesion. 7 The NOTCH1 accumulation on the plasma membranes between neighboring cells and the rare observation of the activated form support this notion. Reduced Notch expression may facilitate the cell dissociation and movement that are required for regenerative epithelium and cancer invasion.
Altogether, we assume that NOTCH1 functions in two ways: it mediates the balance between populations of basal cells and differentiated cells in normal epithelium by symmetric and asymmetric activation; and in pathological conditions, such as wound healing, precancer and cancer, its expression is reduced, which converts the cells into an activated and immature state.
Impaired asymmetric cell division affects epidermal Notch signaling and results in defects in stratification and differentiation, suggesting that Notch is an effector of asymmetric cell division. 41 The mechanism of asymmetric Notch activation is unclear. JAG1, one of the canonical ligands, was expressed in the suprabasal layers (K.S., unpublished observations), which suggests that the signal is directionally transmitted from an apical cell to a basal cell because of these localizations of ligand-and receptor-expressing cells. However, JAG1 was also expressed in the basal cells, and the significance of the co-expression of receptors and ligand in the basal cells is yet to be elucidated. Accumulating evidence indicates that the canonical Notch ligands also act as a cellautonomous repressor of Notch signaling, 26, [42] [43] [44] [45] [46] suggesting that JAG1 expression in the basal cells may inhibit the signaling. Another possible mechanism of the asymmetric activation is the suppression of Notch signaling by protein degradation mediated by Numb, which is distributed differentially in the daughter cells and governs asymmetric cell division. 47, 48 The transcription of NOTCH1 gene is suppressed by TP63(DN) in cervical keratinocytes, 28 and TP63(DN) inhibits differentiation in the oropharyngeal SCC cell line. 49 Our findings using Ca9-22 cells are consistent with these results, suggesting that the interplay between NOTCH1 and TP63(DN) in differentiation is common in non-cornified epithelia of various sites. In addition, we found that TP63(DN) expression was affected by Notch signaling, suggesting a feedback relationship between these factors. It should be noted that this hypothetical NOTCH1-TP63 interplay does not resemble the expression patterns of these factors in cancer tissues, in which TP63 is uniformly expressed in both basal and suprabasal layers of normal epithelium and cancer (data not shown). Thus, the NOTCH1-TP63 interplay is merely one of many mechanisms that govern the epithelial cell behaviors.
In summary, NOTCH1 is expressed predominantly in the basal cells of squamous epithelium, and it is generally downregulated in squamous neoplasms, even at early stages. Reduction of NOTCH1 expression directs the basal cells to cease terminal differentiation, resulting in an immature epithelium, which may have an essential role in the histopathogenesis of dysplastic features commonly observed in precancerous epithelium. These findings suggest that normal epithelial integrity is autonomously maintained by this evolutionarily conserved cell-to-cell signaling system.
